99% Savings - Buy Just @1 Rs X
Geminex is a prescription medicine that is available as a Tablet. Primarily, it is used for the treatment of Bronchitis. Other than this, Geminex has some other therapeutic uses, which have been discussed ahead.
Medical history of the patient along with age and gender determines the dosage of Geminex. Individual symptoms and route of administration also determines the right dosage. This information has been provided in detail in the dosage section.
Geminex also has some side effects, the most common being Nausea or vomiting, Diarrhoea, Dizziness. Apart from the aforementioned side effects, Geminex can also lead to other problems, which have been listed below. These side effects of Geminex are usually temporary and subside with the completion of treatment. Please speak with your doctor if these side effects worsen or persist for a longer duration.
Geminex's effect during pregnancy is Moderate and Severe while nursing. Further, the section on Geminex related warnings talks about Geminex's effects on the liver, heart and kidney.
Geminex can cause adverse effects in certain medical conditions. It is strongly recommended to avoid Geminex in conditions like Myasthenia Gravis (MG), Heart Disease, Tendon Injury (Tendinopathy). Some other conditions that can be affected by Geminex are listed in the contraindications section below.
Additionally, Geminex may also adversely react with other medicines. A complete list of these interactions is given below.
In addition to the above precautions for Geminex, it is important to know that it is not safe while driving, and is not habit-forming.
Geminex is used to treat the following -
Main Benefits
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Adult |
|
Geriatric |
|
Is the use of Geminex safe for pregnant women?
Geminex can cause unwanted side effects in pregnant women. If you experience any side effects, stop taking Geminex right away. Take your doctor's advice before taking it again.
Is the use of Geminex safe during breastfeeding?
Geminex may cause serious side effects in breastfeeding women, so do not take this drug without doctor's advice.
What is the effect of Geminex on the Kidneys?
Geminex rarely harms the kidneys.
What is the effect of Geminex on the Liver?
Geminex does not damage the liver.
What is the effect of Geminex on the Heart?
Very few cases of side effects of Geminex on the heart have been reported.
Geminex should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
Moderate
If you are suffering from any of the following diseases, you should not take Geminex unless your doctor advises you to do so -
Is this Geminex habit forming or addictive?
Forming a habit of Geminex has not been reported.
Is it safe to drive or operate heavy machinery when consuming?
After taking Geminex you may feel sleepy. So it is not advised to perform these activities.
Is it safe?
Geminex should be used only after doctor's advice.
Is it able to treat mental disorders?
No, Geminex cannot treat any kind of mental disorder.
Interaction between Food and Geminex
Taking Geminex with some specific foods may delay its effect. Talk to your doctor about this.
Interaction between Alcohol and Geminex
It is difficult to say anything about the effect of Geminex and alcohol. No research has been done on this yet.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Factive® (gemifloxacin mesylate)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 714
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 579-584